P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc.
SystImmune Inc.
University of Nebraska
Novartis
Incyte Corporation
Travera Inc
Marengo Therapeutics, Inc.
Shantou University Medical College
Eastern Cooperative Oncology Group
Xencor, Inc.
Tel-Aviv Sourasky Medical Center
University Health Network, Toronto
University of Kansas Medical Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Fox Chase Cancer Center
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)